**Question:** Triple screening test for Down syndrome during pregnancy includes all of the following except:

A. Serum alpha-fetoprotein (AFP) levels
B. Human chorionic gonadotropin (hCG) levels
C. Estriol levels
D. Free beta-hCG levels

**Correct Answer:** C. Estriol levels

**Core Concept:**
The triple screening test, also known as the quadruple screening test, is a prenatal screening test used to identify an increased risk of having a baby with Down syndrome (trisomy 21) or other chromosomal abnormalities. It includes measuring four key biomarkers in a pregnant woman's blood: serum alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and free beta-human chorionic gonadotropin (free beta-hCG), which are all involved in fetal development and placental function. Estriol levels are not typically included in the test, as it is not as reliable or sensitive as the other markers.

**Why the Correct Answer is Right:**
The triple screening test is designed to identify increased risks for Down syndrome and other chromosomal abnormalities. Estriol (E3) is a hormone involved in fetal development during the second trimester, particularly in the third trimester. However, its levels are not as reliable as AFP, hCG, and free beta-hCG for detecting Down syndrome during the second trimester when the test is typically conducted.

**Why Each Wrong Option is Incorrect:**

**A.** Serum alpha-fetoprotein (AFP) - AFP is a protein produced by the liver of the developing fetus and is cleared by the placenta. Elevated AFP levels may indicate an increased risk of Down syndrome or other abnormalities like neural tube defects.

**B.** Human chorionic gonadotropin (hCG) - hCG is a hormone produced by the placenta and is essential for maintaining pregnancy. Elevated hCG levels may indicate an increased risk of Down syndrome and other chromosomal abnormalities.

**D.** Free beta-human chorionic gonadotropin (free beta-hCG) - Similar to hCG, free beta-hCG is a hormone produced by the placenta that plays a crucial role in maintaining pregnancy. Elevated free beta-hCG levels may indicate an increased risk of Down syndrome and other chromosomal abnormalities.

**Core Concept:**
The triple screening test aims to identify fetal chromosomal abnormalities, particularly trisomy 21 (Down syndrome). It measures AFP, hCG, and free beta-hCG levels in a pregnant woman's blood to assess the risk of Down syndrome and other chromosomal abnormalities. Estriol (E3) is not included in the test because it is not as reliable as AFP, hCG, and free beta-hCG in detecting Down syndrome during the second trimester when the test is typically conducted.